Peter Vozzo | Investor Relations-Westwicke Partners |
Jack Khattar | Chief Executive Officer |
Greg Patrick | Chief Financial Officer |
Annabel Samimy | Stifel |
David Steinberg | Jefferies |
John Boris | SunTrust |
Bill Tanner | Cantor Fitzgerald |
Patrick Trucchio | Berenberg Capital Markets |
David Amsellem | Piper Jaffray |
Ken Trbovich | Janney |
Good morning, ladies and gentlemen, and welcome to Supernus Pharmaceuticals’ Second Quarter 2018 Financial Results Conference Call. At this time, all participants are in a listen-only mode. Later we will conduct a question-and-answer session and instructions will follow at that time.
As a reminder, this conference call is being recorded. I would now like to turn the conference over to Peter Vozzo, Westwicke Partners, Investor Relations for Supernus Pharmaceuticals.